GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in healthcare research, largely due to its impressive impact on treating ailments such as type 2 diabetes and excess body fat. New research have shown that beyond glucose regulation, GLP-1 drugs offer potential for circulatory well-being and even brain